Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in interests in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned Director and Person Discharging Managerial Responsibility (PDMR) on 1 May 2014:
Sir Andrew Witty
|
GSK Deferred Annual Bonus Plan
Exercise of a nil priced option over 37,182 shares and 14,799 shares granted on 24 February 2011, both of which vested on 24 February 2014 under the GlaxoSmithKline Deferred Annual Bonus Plan. GlaxoSmithKline delivered the net of tax value in shares being 27,549.
|
Mr D S Redfern
|
Exercise of a nil priced option over 8,837 shares and 3,518 shares granted on 24 February 2011, both of which vested on 24 February 2014 under the GlaxoSmithKline Deferred Annual Bonus Plan. GlaxoSmithKline delivered the net of tax value in shares being 6,548.
|
The Company and the above-mentioned Director and PDMR were advised of these transactions on 2 May 2014.
This notification relates to transactions notified in accordance with paragraph 3.1.4R(1)(a) of the Disclosure and Transparency Rules.
V A Whyte
Company Secretary
2 May 2014